G

Galapagos

882 employees

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Health Care
Medical
Biopharma
Clinical Trials

Date founded

1999

Investments made

U

Undisclosed raised undisclosed on July 1, 2013

Investors: Van Herk Groep, University Medical Center Groningen (UMCG) and Galapagos

Funding rounds raised

Total raised

$5.1B

from 4 investors over 4 rounds

G

Galapagos raised $5.1B on July 14, 2019

Investors: Gilead Sciences

G

Galapagos raised $2.9M on January 22, 2015

Investors: University of Antwerp

G

Galapagos raised undisclosed on January 6, 2014

Investors: Van Herk Groep

G

Galapagos raised $1.1M on March 11, 2009

Investors: IWT

FAQ